Thus, in a controlled model of VEGF‐induced angiogenesis, Apelin and VEGF induce similar downstream pathways and genes relevant for endothelial cell proliferation and blood vessel sprouting, suggesting that Apelin inhibition could complement and potentiate current anti‐angiogenic cancer treatment. This evidence concerns the gene APLN and cancer.